Angioedema - 189 Studies Found
Completed |
: A Study of Icatibant in Patients With Acute Attacks of Hereditary Angioedema (FAST-3) : Hereditary Angioedema : 2009-06-02 :
|
Completed |
: Subcutaneous Treatment With Icatibant for Acute Attacks of Hereditary Angioedema (HAE) : Hereditary Angioedema : 2007-07-12 :
|
Withdrawn |
: Study to Evaluate Ecallantide in Paediatric Patients With Acute Attacks of Hereditary Angioedema : Hereditary Angioedema : 2010-12-02 : Biological: ecallantide 10 - 30mg subcutaneous injection. |
Completed |
: CINRYZE for the Treatment of Hereditary Angioedema Attacks in Children Under the Age of 12 : Hereditary Angioedema : 2010-03-24 : Biological: CINRYZE Other Name: C1 inhibitor [human] |
Completed |
: Double-Blind, Multiple Ascending Dose Study to Assess Safety, Tolerability and Pharmacokinetics of DX-2930 in Hereditary Angioedema (HAE) Subjects : Hereditary Angioedema : 2014-03-17 :
|
Completed |
: Efficacy Study of DX-88 (Ecallantide) to Treat Acute Attacks of Hereditary Angioedema (HAE) : Hereditary Angioedema : 2007-04-04 :
|
Active, not recruiting |
: A Pharmacokinetic, Tolerability and Safety Study of Icatibant in Children and Adolescents With Hereditary Angioedema : Hereditary Angioedema (HAE) : 2011-06-28 : Drug: icatibant Single dose of icatibant 0.4 mg/kg subcutaneous(SC) up to a maximal dose of 30 mg |
Recruiting |
: Study to Assess the Tolerability and Safety of Ecallantide in Children and Adolescents With Hereditary Angioedema : Hereditary Angioedema Types I and II : 2013-04-04 : Drug: Ecallantide subcutaneous dosing For acute attacks of Hereditary Angioedema in children and adolesc |
Completed |
: A European Post-Authorisation Observational Study Of Patients With Hereditary Angioedema : Hereditary Angioedema (HAE) : 2012-02-16 |
Completed |
: Efficacy and Safety Study of DX-88 to Treat Acute Attacks of Hereditary Angioedema (HAE) : Hereditary Angioedema (HAE) : 2005-12-05 :
|